Biological medicines have changed the treatment pathway for many debilitating conditions, but the high price tag is a barrier, and many patients are denied access to these life-changing and life-saving medicines. This, combined with the increasing prevalence of chronic diseases has led to higher demand for available, affordable drugs that can improve health and utilization.
The advances in our understanding of pain mechanisms and a large number of clinical studies have not translated into more effective, affordable, and safer pharmaceutical products. But Worldwide Clinical Trials can help you change that.
A hands-on approach provides significant advantages that can shorten drug development timelines and reduce development risk.
CRO manages multiple, complex statistical analysis deliverables for a program of studies, CDISC compliant outputs, and data pooling for NDA submission to the FDA with minimal sponsor oversight.
A specialized partner in Hematology and Oncology clinical development.
Gain a competitive advantage for your study in the ever-evolving landscape of hematology and oncology drug and biologic clinical development.
The T-cell Receptor Sequencing assay, using RNA Sequencing, is part of an immuno-oncology assay portfolio and is available for RUO or GCP application
Bioinformatics big data solutions using next generation sequencing to enable genomics studies from discovery to clinical biomarker development.
Q2 Solutions testing capabilities for infectious diseases and vaccine development, including TB, HIV, Malaria, HPV, Ebola, RSV, and other infectious agents.
Improve cash management and financial risk mitigation as well as site payment transparency, control and accuracy, while reducing payment-related workload and costs, with Bioclinica’s Site & Patient Payments platform.
|
|
|
|
|
|
|
|
|